![Nutrients | Free Full-Text | Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G0/G1 to Apoptosis in HCT116 Human Colorectal Carcinoma Cells | HTML Nutrients | Free Full-Text | Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G0/G1 to Apoptosis in HCT116 Human Colorectal Carcinoma Cells | HTML](https://www.mdpi.com/nutrients/nutrients-11-00770/article_deploy/html/images/nutrients-11-00770-g006.png)
Nutrients | Free Full-Text | Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G0/G1 to Apoptosis in HCT116 Human Colorectal Carcinoma Cells | HTML
![The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress | Cell Death & Disease The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-019-1824-6/MediaObjects/41419_2019_1824_Fig7_HTML.png)
The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress | Cell Death & Disease
![Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2: Molecular Therapy - Oncolytics Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2: Molecular Therapy - Oncolytics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/576efb14-5f70-4395-ae7c-4fbb052a0db3/gr7_lrg.jpg)
Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2: Molecular Therapy - Oncolytics
![Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy | SpringerLink Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00280-015-2901-x/MediaObjects/280_2015_2901_Fig3_HTML.gif)
Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy | SpringerLink
![LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan - ScienceDirect LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S075333222100874X-ga1.jpg)
LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan - ScienceDirect
![Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer | Exosome RNA Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer | Exosome RNA](https://onlinelibrary.wiley.com/cms/asset/81c4aaec-7e37-4236-bf7b-8fb25d39b078/jcp30566-gra-0001-m.jpg)
Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer | Exosome RNA
![Oxaliplatin Uses JNK to Restore TRAIL Sensitivity in Cancer Cells Through Bcl-xL Inactivation - Gastroenterology Oxaliplatin Uses JNK to Restore TRAIL Sensitivity in Cancer Cells Through Bcl-xL Inactivation - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c0d12efd-d831-46e6-8d33-9e55fca068f7/gr1_lrg.jpg)
Oxaliplatin Uses JNK to Restore TRAIL Sensitivity in Cancer Cells Through Bcl-xL Inactivation - Gastroenterology
![Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradation | Scientific Reports Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradation | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-04383-4/MediaObjects/41598_2017_4383_Fig1_HTML.jpg)
Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradation | Scientific Reports
![Frontiers | Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy | Pharmacology Frontiers | Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy | Pharmacology](https://www.frontiersin.org/files/Articles/607780/fphar-11-607780-HTML-r1/image_m/fphar-11-607780-g001.jpg)
Frontiers | Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy | Pharmacology
![Dose and Sequence Dependent Synergism from the Combination of Oxaliplatin with Emetine and Patulin Against Colorectal Cancer | Bentham Science Dose and Sequence Dependent Synergism from the Combination of Oxaliplatin with Emetine and Patulin Against Colorectal Cancer | Bentham Science](http://www.eurekaselect.com/images/graphical-abstract/acamc/20/2/005.jpg)
Dose and Sequence Dependent Synergism from the Combination of Oxaliplatin with Emetine and Patulin Against Colorectal Cancer | Bentham Science
Interactions of oxaliplatin with the cytoplasmic thiol containing ligand glutathione - Metallomics (RSC Publishing)
![Oxaliplatin derived monofunctional triazole-containing platinum(II) complex counteracts oxaliplatin-induced drug resistance in colorectal cancer - ScienceDirect Oxaliplatin derived monofunctional triazole-containing platinum(II) complex counteracts oxaliplatin-induced drug resistance in colorectal cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0045206821000122-ga1.jpg)
Oxaliplatin derived monofunctional triazole-containing platinum(II) complex counteracts oxaliplatin-induced drug resistance in colorectal cancer - ScienceDirect
![Enhancement of oxaliplatin-induced colon cancer cell apoptosis by alantolactone, a natural product inducer of ROS Enhancement of oxaliplatin-induced colon cancer cell apoptosis by alantolactone, a natural product inducer of ROS](https://www.ijbs.com/v15/p1676/toc.jpg)
Enhancement of oxaliplatin-induced colon cancer cell apoptosis by alantolactone, a natural product inducer of ROS
![Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy | SpringerLink Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00280-015-2901-x/MediaObjects/280_2015_2901_Fig5_HTML.gif)
Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy | SpringerLink
![Analysis of Oxaliplatin Resistance in Colorectal Cancer Cells by Combined Proteomics and Phosphoproteomic | Bentham Science Analysis of Oxaliplatin Resistance in Colorectal Cancer Cells by Combined Proteomics and Phosphoproteomic | Bentham Science](https://www.eurekaselect.net/public/images/graphical-abstract/cp/18/2/010.jpg)